Application of clinical trial inclusion criteria to clinical practice patients to quantify the burden of CNS metastases on health-related quality of life and healthcare resource use in patients with NSCLC

Lung Cancer(2020)

Cited 0|Views15
No score
Abstract
•Clinical practice data on the burden of CNS disease in NSCLC.•No decline in quality of life over 3 months in patients with/without CNS metastases.•Minor differences in quality of life and resource use observed between cohorts.•Differences focussed on comorbidities, diagnostic tests and length of hospital stay.•Supportive of clinical trial inclusion of well-selected patients with CNS disease.
More
Translated text
Key words
CNS metastases,Healthcare resource use,Health-related QoL,NSCLC,Clinical practice
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined